Category: Expert Session
On Thursday 9 November 2017, we will discuss the results of our annual (Bio)Pharma Salary Survey. Only companies that took part in the Salary Survey can attend this meeting.
The (Bio)Pharma Salary Survey provides an overview of the salaries of R&D and support functions in the life sciences and biopharmaceutical sector - enabling companies to compare their salaries with the rest of the market.
Since 2011, flanders.bio works together with Korn Ferry Hay Group for the execution of the survey. This year's survey includes 12.229 incumbents from 36 life sciences companies. The following companies actively took part this year: Ablynx - Bayer Cropscience - Biocartis - Bone Therapeutics - Celyad - eTheRNA immunotherapies - Galapagos - IDDI (International Drug Development Institute) - MyCartis - Pi life sciences consultancy - Quality Assistance - ReGenesys – Valesta.
Managing Director, flanders.bio
Market Leader Productized Services Belux, Korn Ferry Hay Group
Account Manager, Korn Ferry Hay Group
Henk Joos, Managing Director, flanders.bio
Geert Du Bois & Jan Machtelinckx, Korn Ferry Hay Group
Korn Ferry Hay Group, Avenue Louise / Louizalaan 489, 1050 Brussels
Included in the participation fee for the survey.
FLANDERS.BIO MEMBER BENEFIT: flanders.bio members receive an important reduction on the participation fee for the survey.